Soluble HLA-I in rheumatic diseases

Human Immunology

Volumn 59, Issue 10, 1998, Pages 644-649

  Wolf, Robert E ^a   Adamashvili, Irena M ^a   Gelder, Frank B ^a   Hall, Vicky C ^a   Fraser, Patricia A ^b   McDonald, John C ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS;

AFRICAN CONTINENTAL ANCESTRY GROUP; ARTHRITIS, RHEUMATOID; EUROPEAN CONTINENTAL ANCESTRY GROUP; GEORGIA (REPUBLIC); HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LOUISIANA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYOSITIS; RHEUMATIC DISEASES; SCLERODERMA, SYSTEMIC; SOLUBILITY; WEST INDIES;

EID: 0031751433     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00071-8     Document Type: Article

References (37)

1. Reisfeld R.A., Allison J.P., Ferrone S., Pellegrino M.A., Poulik M.D. HLA-antigens in serum and urine isolation, characterization and immunogenic . Transplant Proc. 8:1976;173.
2. McDonald J.C., Gelder F.B., Aultman D.F., Landreneau M., McMillan R., Sorrells D., Wen-Haui L. HLA in human serum quantitation of class I by enzyme immunoassay. Transplantation. 54:1992;444.
3. Pellegrino M.A., Russo C., Allison J. HLA antigens in serum. Methods Enzymol. 108:1984;614.
4. Benier I., Dautigny A., Colombani J., Jolles P. Purification of HLA antigens from the urine of diseased and healthy individuals. FEBS Lett. 45:1974;308.
5. Alvarez-Cermeno J., Casado C., Villar L., Ferreira A., Varela J., Dominguez M., Bootello A., Najera R., Ganzalez-Porque P. Soluble class I antigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neurol Scand. 82:1990;14.
6. Jendro M.J., Goronzy J., Weyand C.M. Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity. 8:1981;289.
7. Comuzio S., Puppo F., Ruzzenenti. Simple ELISA method for the evaluation of soluble HLA class I antigens in human serum. Clin Lab Analysis. 5:1981;278.
8. Krangel M.S. Two forms of HLA class I molecules in human plasma. Hum Immunol. 20:1984;155-165.
9. Kamada N., Brons G., Davies H.S. Fully allogenic liver grafting in rats induces a state of systemic non-reactivity to donor transplantation antigens. Transplantation. 29:1980;429.
10. King D.W., Reed E., Suciu-Foca N. Complexes of soluble antigens and anti-HLA autoantibodies in human sera possible role in maintenance of self-tolerance . Immunol Res. 8:1989;249.
11. Tsuchiya N., Shiota M., Yamaguchi A., Ito K. Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum. 39:1996;792.
12. Filaci G., Contini P., Brenci S., Gazzola P., Lanza L., Scudeletti M., Indiveri F., Mancardi G.L., Puppo F. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. Human Immunol. 54:1997;54.
13. Adamashvili I., McVie R., Gelder Gautreaux M., Jaramillo J., Roggero R., McDonald J. Soluble HLA class I antigens in patients with type I diabetes and their family members. Human Immuno. 55:1977;176.
14. Adamashvili I.M., Fraser P.A., McDonald J.C. Soluble HLA serum concentrations and HLA allotypes. Transplantation. 61:1996;984.
15. Adamashvili I.M., McDonald J.C., Fraser F.A., Milford E., Pressly T., Gelder F.B. Soluble class I antigens in patients with rheumatoid arthritis and their families. J Rheumatol. 22:1995;1025.
16. Fraser P.A., Moore Stein R. Complotypes in individuals of African origin frequencies and possible extended MHC haplotypes . Immunogenetics. 31:1990;89.
17. Fraser P.A., Awdeh Z.L., Ronco P. C4B gene polymorphisms among African and African-American HLA-Bw12-DRw18 haplotypes. Immunogentics. 34:1991;52.
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumol 1271, 1982.
19. Arnet F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra T.A., Medsger T.A. Jr, Mitchell D.M., Neustadt D.H., Pinals R.S., Schaller J.G., Sharp J.T., Wilder R.L., Hunder G.G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumol. 31:1988;315.
20. Masi A.T., Rodnan G.P., Medsger T.A. Jr, Altman D.F., D'Angelo W.A., Fries J.F., LeRoy E.C., Kirsner A.B., Mackenzie A.H., McShane D.J., Myers A.R., Sharp G.C. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheumol. 23:1980;581.
21. Gelder F.B., McDonald J.C., Landreneau M.D., McMillan R.W., Autman D.F. Identification, characterization and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients. Ann Surg. 213:1991;591.
22. Nakane P.K., Kawavi A. Peroxidase labeled antibody a new method of conjugation . J Histochem Cytochem. 22:1974;1084.
23. Davies H.F.F.S., Pollard S.G., Calne R.Y. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation. 47:1989;524.
24. Pollard S.G., Davies H.F.F.S., Calne R.Y. Perioperative appearance of serum class I antigen during liver transplantation. Transplantation. 49:(3):1990;659.
25. Sumimoto R., Kamada N. Evidence that soluble class I antigen in donor serum induces the suppression of heart allograft rejection in rats. Immunol Lett. 26:1990;81.
26. Grosse-Wilde H., Blasczyk R., Westhoff U. Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations. Tissue Antigens. 39:1992;74.
27. Krangel M.S. Secretion of HLA-A and -B via an alternative RNA splicing pathway. J Exp Med. 163:1986;1173.
28. Kao K.J., Scornik J.C., Riley W.J., McQueen C. Association between HLA phenotype and HLA concentration in plasma or platelets. Human Immunol. 21:1988;115.
29. Dobbe L.M.E., Stam N.J., Neeffjes J.J., Giphart M. Biochemical complexity of serum HLA class I molecules. Immunogenetics. 27:1988;203.
30. Zavazava N., Westphal E., Muller-Ruchholtz W. Characterization of soluble-HLA molecules in sweat and quantitative HLA differences in serum of healthy individuals. Immunogenetics. 17:1990;387.
31. Doxiadis I., Westhoff U., Grosse-Wilde H. Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut. 59:1989;449.
32. Allison J.P., Pellegrino M.A., Ferrone S., Callahan G., Reisfeld R.A. Biologic and chemical characterization of HLA antigens in human serum. J Immunol. 118:1997;1004.
33. Tiwari J., Terasaki P. HLA and disease association. 1985;Springer-Verlag, New York.
34. Adamashvili I.M., Makarova O.V., Kvachadze I.M., Trubrikov V., Zamchuk L. Antibodies to nucleic acids in systemic lupus erythematosus and rheumatoid arthritis patients and their relatives. Immunology Letters. 6:1983;33.
35. Zeben D.V., Hazes M.W., Zwinderman A.H. Factors predicting outcome of rheumatoid arthritis results of a follow up study . J Rheumatol. 20:1993;1288.
36. Nossent J.C. Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients. Sem Arthritis Rheumat. 23:1993;16.
37. Higihara M., Shimura T., Yamamoto K., Sujirachato K., Tsuji S., Yamamoto M., Tsuji K. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus. Tokai J Exp Clin Med. 18:1993;61.